Retina Today (@retinatoday) 's Twitter Profile
Retina Today

@retinatoday

Retina Today delivers the latest research and clinical developments in medical retina, retinal surgery, vitreous, diabetes, & imaging. A BMC Vision publication.

ID: 22146160

linkhttp://www.retinatoday.com calendar_today27-02-2009 14:46:42

7,7K Tweet

21,21K Followers

1,1K Following

Retina Today (@retinatoday) 's Twitter Profile Photo

How does overactivation of the complement system affect lesion development and progression of geographic atrophy? Read to learn the latest insights from Dr. Khanani. ow.ly/reje50VWu7q

How does overactivation of the complement system affect lesion development and progression of geographic atrophy? Read to learn the latest insights from Dr. Khanani. ow.ly/reje50VWu7q
Retina Today (@retinatoday) 's Twitter Profile Photo

On the latest New #Retina Radio Journal Club with VBS, Drs. Lediana Goduni, Alexis Warren, and Joshua Uhr unpack a TriNetX-based study on GLP-1s and age-related ocular disease risk—and debate whether these data should change how we counsel patients: ow.ly/hQQT50VXSTJ

Retina Today (@retinatoday) 's Twitter Profile Photo

At ARVO 2025, New Retina Radio sat down with Drs. David Miller and Robert Wang to review real-world dosing of next-gen anti-VEGFs and the state of TKIs. Listen here 🎧: ow.ly/jAcP50W0RN7

Retina Today (@retinatoday) 's Twitter Profile Photo

Drs. Fehrina Ali and Roger Goldberg review how sustained-release tyrosine kinase inhibitors may enable retinal specialists to extend treatment intervals for nAMD patients and reduce injection burden. Read more: bit.ly/43Ci8pk #sponsored #DURAVYU #vorolanib #EYP1901

Drs. Fehrina Ali and Roger Goldberg review how sustained-release tyrosine kinase inhibitors may enable retinal specialists to extend treatment intervals for nAMD patients and reduce injection burden. Read more: bit.ly/43Ci8pk

#sponsored #DURAVYU #vorolanib #EYP1901
Retina Today (@retinatoday) 's Twitter Profile Photo

Gain a firmer grasp on OCTA's potential to improve your diagnosis and characterization of disease in this dialogue between Yasha Modi, MD, and Katherine Talcott, MD: ow.ly/IrSz50W1Io5 #sponsored

Gain a firmer grasp on OCTA's potential to improve your diagnosis and characterization of disease in this dialogue between Yasha Modi, MD, and Katherine Talcott, MD: ow.ly/IrSz50W1Io5 #sponsored
Retina Today (@retinatoday) 's Twitter Profile Photo

Want to catch up on ARVO talks? We’ve got you covered with video highlights on Eyetube! ARVO faculty discuss diabetes care, including novel therapies under investigation and the effect of new systemic meds on the eye: ow.ly/tq1Z50W2NGU

Want to catch up on ARVO talks? We’ve got you covered with video highlights on Eyetube! ARVO faculty discuss diabetes care, including novel therapies under investigation and the effect of new systemic meds on the eye: ow.ly/tq1Z50W2NGU
Retina Today (@retinatoday) 's Twitter Profile Photo

Rene Choi, MD, PhD, is our next One to Watch! He knew retina was his place after conducting research on retinal regeneration in a frog model of retinitis pigmentosa. Learn more about Dr. Choi’s background, mentors, and pearls for new surgeons here: ow.ly/3rKt50W3ze7

Retina Today (@retinatoday) 's Twitter Profile Photo

📣 Register now to attend 💻🗣️ Photobiomodulation Coding, Billing, and Reimbursement—a webinar on reimbursement considerations for the Valeda® Light Delivery System for dry AMD. Save your seat for 6/26 at 8:30pm EDT! ow.ly/byoS50W4TSh #sponsored

📣 Register now to attend 💻🗣️ Photobiomodulation Coding, Billing, and Reimbursement—a webinar on reimbursement considerations for the Valeda® Light Delivery System for dry AMD. Save your seat for 6/26 at 8:30pm EDT! ow.ly/byoS50W4TSh #sponsored
Retina Today (@retinatoday) 's Twitter Profile Photo

Adrian Au, MD, PhD, is our next ⭐️Rising Star in Retina ⭐️ He is a 2nd-year vitreoretinal surgery fellow at UCLA, and he hopes to contribute to diagnostic and therapeutic innovations during his career. Learn more about his path to retina here: ow.ly/ctRq50W5CcB

Retina Today (@retinatoday) 's Twitter Profile Photo

Did you miss ARVO this year? We didn’t, and we have your video meeting highlights to catch you up on the latest happenings. Experts share pearls on treating GA, treatment-naïve wet AMD, and symptomatic vitreous floaters: ow.ly/MSoZ50W6rQu

Did you miss ARVO this year? We didn’t, and we have your video meeting highlights to catch you up on the latest happenings. Experts share pearls on treating GA, treatment-naïve wet AMD, and symptomatic vitreous floaters: ow.ly/MSoZ50W6rQu
Retina Today (@retinatoday) 's Twitter Profile Photo

Explore innovations in retinal care in the May/June issue of Retina Today! From gene therapy to AI chatbots, see how we're reshaping AMD management. Read more at RetinaToday.com.

Explore innovations in retinal care in the May/June issue of Retina Today! From gene therapy to AI chatbots, see how we're reshaping AMD management. 

Read more at RetinaToday.com.
Retina Today (@retinatoday) 's Twitter Profile Photo

[💻🗣️ Webinar] Navigating Valeda reimbursement pathways for dry AMD treatment. Register now for the webinar on Thursday, June 26! ow.ly/bWm150W7WH3 #sponsored

[💻🗣️ Webinar] Navigating Valeda reimbursement pathways for dry AMD treatment. Register now for the webinar on Thursday, June 26! ow.ly/bWm150W7WH3 #sponsored
Retina Today (@retinatoday) 's Twitter Profile Photo

At ARVO 2025, New Retina Radio sat down with Drs. Marion Munk and Diana Do to discuss antisense oligonucleotide targeting of TGF-beta in wet AMD/DME and the latest data on photobiomodulation. Listen here 🎧: ow.ly/pppu50W8jcW

Retina Today (@retinatoday) 's Twitter Profile Photo

We had a fantastic time at the 2025 Duke AVS Course, and we captured many of the highlights on video! Check out our meeting coverage, now available on Eyetube. ow.ly/JSXO50W95GT

We had a fantastic time at the 2025 Duke AVS Course, and we captured many of the highlights on video! Check out our meeting coverage, now available on Eyetube. ow.ly/JSXO50W95GT
Retina Today (@retinatoday) 's Twitter Profile Photo

Exclusively available from Bausch + Lomb, the Cohen-Benner Surgical Contact Lens brings clarity and stability to your surgical experience with excellent visualization of the macula. Lens on. Hands off. Learn more at ow.ly/WRnT50Wanrs #bauschsurgical #ophthalmology #ad

Exclusively available from Bausch + Lomb, the Cohen-Benner Surgical Contact Lens brings clarity and stability to your surgical experience with excellent visualization of the macula. Lens on. Hands off. Learn more at ow.ly/WRnT50Wanrs #bauschsurgical #ophthalmology #ad
Retina Today (@retinatoday) 's Twitter Profile Photo

Calling all incoming 1st-year retina fellows! Register NOW for the 15th Annual Mass Eye and Ear Vitrectomy Course! Join us July 11-12 in Boston for this unique workshop that covers the theory and practice of vitreoretinal surgery: ow.ly/G9bF50Wb8nc #ad

Calling all incoming 1st-year retina fellows! Register NOW for the 15th Annual Mass Eye and Ear Vitrectomy Course! Join us July 11-12 in Boston for this unique workshop that covers the theory and practice of vitreoretinal surgery: ow.ly/G9bF50Wb8nc #ad
Retina Today (@retinatoday) 's Twitter Profile Photo

The 2025 Duke AVS Course was packed with top-notch education, and we have video highlights for you! Experts shared pearls for multimodal imaging, AI in clinical trials, GLP-1 receptor agonists and DR, MTM, and more. Check it out: ow.ly/OK2950WbWLe

The 2025 Duke AVS Course was packed with top-notch education, and we have video highlights for you! Experts shared pearls for multimodal imaging, AI in clinical trials, GLP-1 receptor agonists and DR, MTM, and more. Check it out: ow.ly/OK2950WbWLe
Retina Today (@retinatoday) 's Twitter Profile Photo

⚠️ Last chance to register! ⚠️ Join “Photobiomodulation Coding, Billing, and Reimbursement” to gain practical guidance on navigating reimbursement pathways for Valeda treatment for dry AMD. Register now for the webinar on 6/26: ow.ly/e0qt50Wc4np #sponsored

⚠️ Last chance to register! ⚠️ Join “Photobiomodulation Coding, Billing, and Reimbursement” to gain practical guidance on navigating reimbursement pathways for Valeda treatment for dry AMD. Register now for the webinar on  6/26: ow.ly/e0qt50Wc4np #sponsored
Retina Today (@retinatoday) 's Twitter Profile Photo

Predatory "cell therapy" clinics are on the decline. How many still remain? Join Drs. Maria Berrocal and Ajay Kuriyan on Clinical Minute: Retina to find out ➡️ ow.ly/NUT650Wc4pc

Predatory "cell therapy" clinics are on the decline. How many still remain? Join Drs. Maria Berrocal and Ajay Kuriyan on Clinical Minute: Retina to find out ➡️  ow.ly/NUT650Wc4pc